Skip to main content

Table 2 Propofol usage, time parameters, and incidence of adverse events

From: Use of intravenous lidocaine for dose reduction of propofol in paediatric colonoscopy patients: a randomised placebo-controlled study

Variable

Control group

Lidocaine group

OR

P value (95% CI)

Propofol induction dose, mg

63.2 ± 10.1

57.4 ± 11.6

 

0.112(−13.05, 1.42)

Propofol maintenance dose, mg

136.2 ± 49.6

71.2 ± 26.7

 

<0.001(−90.78, −39.22)

Total propofol dose, mg

199.4 ± 57.6

128.6 ± 30.4

 

<0.001(−100.60, −41.02)

Operation time, min

25.9 ± 7.0

24.0 ± 5.8

 

0.357(−6.03, 2.23)

Awakening time, min

11.2 ± 2.4

4.8 ± 1.4

 

<0.001(−7.67, −5.13)

Recovery time, min

13.7 ± 2.7

7.8 ± 2.1

 

<0.001(−7.45, −4.35)

Involuntary movement n (%)

8 (40)

2 (10)

0.17

0.028 (0.03, 0.92)

Hypotension n (%)

3 (5)

2 (10)

0.63

>0.999 (0.09, 4.24)

Bradycardia n (%)

1 (5)

3 (15)

3.35

0.605 (0.32, 35.36)

Hypoxia n (%)

2 (10)

1 (5)

0.47

>0.999 (0.04, 5.69)

  1. Data are presented as mean ± SD or number(%); OR Odds ratio, CI Confidence interval; P < 0.05 denotes statistical significance